Lincobac 300

Lincobac 300

Lincobac 300 Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Swine intended for human consumption should not be slaughtered within 48 hours of latest treatment.

Human Warnings:

Not for use in humans. Keep out of reach of children.

CAUTION: If no improvement is noted within 48 hours, consult a veterinarian.

Human Warnings:

Not for use in humans. Keep out of reach of children.

CAUTION: If no improvement is noted within 48 hours, consult a veterinarian.

CAUTION: If no improvement is noted within 48 hours, consult a veterinarian.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

INDICATIONS FOR SWINE:

LincoBac™ 300 is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as staphylococci, streptococci, Erysipelothrix and Mycoplasma spp. It is also indicated for the treatment of mycoplasma pneumonia.

History

There is currently no drug history available for this drug.

Other Information

LincoBac™ 300

(lincomycin injection, USP)

Injection

Swine Antibiotic

For use in swine weighing 300 pounds or more.

For Intramuscular Use in Swine Only

LincoBac™ 300 contains lincomycin hydrochloride, an antibiotic produced by Streptomyces lincolnensis var. lincolnensis which is chemically distinct from all other clinically available antibiotics and is isolated as a white crystalline solid.

Lincobac 300 Manufacturers


  • Mwi/vetone
    Lincobac 300 (Lincomycin) Injection [Mwi/vetone]

Login To Your Free Account